Related Experiment Video
Updated: Aug 4, 2026

The Mouse Round-window Approach for Ototoxic Agent Delivery: A Rapid and Reliable Technique for Inducing Cochlear Cell Degeneration
Published on: November 26, 2015
Unilateral vestibulotoxicity due to systemic gentamicin therapy
1Department of Neurology, Alfred Hospital, Melbourne, Australia. John.Waterston@med.mnash.edu.au
Abstract:
Systemic gentamicin can cause acute bilateral, simultaneous, symmetrical loss of vestibular function manifested by symptoms and signs of chronic vestibular insufficiency (ataxia and oscillopsia). We report 6 patients presenting with ataxia and oscillopsia, but without a history of vertigo, who had severe unilateral loss of vestibular function on caloric testing. The absence of vertigo in these patients could be explained by two possible mechanisms: either, the unilateral loss of vestibular function was subacute, occurring over several days so that compensation could occur, or bilateral vestibular loss occurred which was then followed by asymmetrical recovery of vestibular function. The second hypothesis is supported by the observation that vestibular hair cells can regenerate after aminoglycoside damage.
Related Concept Videos
The Vestibular System
Equilibrium and Balance
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

